varenicline 0.03 MG/ACTUAT Nasal Spray [Tyrvaya]
- RxCUI
- 2572371
- RxNorm name
- varenicline 0.03 MG/ACTUAT Nasal Spray [Tyrvaya]
- Display name
- varenicline 0.03 MG/ACTUAT Nasal Spray [Tyrvaya]
- Full name
- varenicline 0.03 MG/ACTUAT Nasal Spray [Tyrvaya]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:45
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tyrvaya | VARENICLINE | Oyster Point Pharma, Inc. | 014c93dc-5737-479c-a9f0-aaadac1ac298 | 2024-02-12 | Adverse reactions | 2572371 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 014c93dc-5737-479c-a9f0-aaadac1ac298 | tyrvaya 0.03 MG/ACTUAT Nasal Spray [PSN] · varenicline 0.03 MG/ACTUAT Nasal Spray [Tyrvaya] [SBD] · Tyrvaya 0.03 MG per 0.05 ML Nasal Spray [SY] · Tyrvaya 0.03 MG/ACTUAT Nasal Spray [SY] | 4 | 14 | These highlights do not include all the information needed to use TYRVAYA safely and effectively. See full prescribing information for TYRVAYA. TYRVAYA ® (varenicline solution) nasal spray Initial U.S. Approval: 2006 | 20240212 |